1. Home
  2. UNCY vs SKLZ Comparison

UNCY vs SKLZ Comparison

Compare UNCY & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • SKLZ
  • Stock Information
  • Founded
  • UNCY 2016
  • SKLZ 2012
  • Country
  • UNCY United States
  • SKLZ United States
  • Employees
  • UNCY 22
  • SKLZ N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • SKLZ EDP Services
  • Sector
  • UNCY Health Care
  • SKLZ Technology
  • Exchange
  • UNCY Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • UNCY 71.3M
  • SKLZ 80.3M
  • IPO Year
  • UNCY 2021
  • SKLZ N/A
  • Fundamental
  • Price
  • UNCY $0.64
  • SKLZ $6.26
  • Analyst Decision
  • UNCY Strong Buy
  • SKLZ Buy
  • Analyst Count
  • UNCY 4
  • SKLZ 2
  • Target Price
  • UNCY $6.38
  • SKLZ $10.75
  • AVG Volume (30 Days)
  • UNCY 889.6K
  • SKLZ 64.4K
  • Earning Date
  • UNCY 05-14-2025
  • SKLZ 05-08-2025
  • Dividend Yield
  • UNCY N/A
  • SKLZ N/A
  • EPS Growth
  • UNCY N/A
  • SKLZ N/A
  • EPS
  • UNCY N/A
  • SKLZ N/A
  • Revenue
  • UNCY N/A
  • SKLZ $92,644,000.00
  • Revenue This Year
  • UNCY N/A
  • SKLZ $0.20
  • Revenue Next Year
  • UNCY $1,422.24
  • SKLZ $14.10
  • P/E Ratio
  • UNCY N/A
  • SKLZ N/A
  • Revenue Growth
  • UNCY N/A
  • SKLZ N/A
  • 52 Week Low
  • UNCY $0.20
  • SKLZ $3.54
  • 52 Week High
  • UNCY $0.96
  • SKLZ $7.48
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 49.67
  • SKLZ 63.27
  • Support Level
  • UNCY $0.56
  • SKLZ $6.14
  • Resistance Level
  • UNCY $0.62
  • SKLZ $6.41
  • Average True Range (ATR)
  • UNCY 0.05
  • SKLZ 0.32
  • MACD
  • UNCY 0.00
  • SKLZ -0.03
  • Stochastic Oscillator
  • UNCY 74.83
  • SKLZ 67.21

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: